{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:51:43Z","timestamp":1790376703597,"version":"4.1.0"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective.<\/jats:title>\n                  <jats:p>Controlled clinical trial data have suggested that identifying asymptomatic cystic fibrosis (CF) patients through newborn screening improves health outcomes of affected children in the first decade of life. However, it is unclear whether these improvements also include a reduction in risk for bronchial infection, the major determinant of CF morbidity. The authors therefore investigated the association between early CF diagnosis and acquisition of Pseudomonas aeruginosa, the major bronchial pathogen, in the first decade of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methodology.<\/jats:title>\n                  <jats:p>Longitudinal data on 3625 CF patients diagnosed between 1982 and 1990 and before 36 months of age were ascertained from the National Cystic Fibrosis Patient Registry. We compared P aeruginosa acquisition in the first 10 years of life among 4 groups: EAD (early asymptomatic diagnosis)\u2014&amp;lt;6 weeks, by pre\/neonatal screening, genotype, family history (n = 157); ESD (early symptomatic diagnosis) (n = 227); LAD (late asymptomatic diagnosis)\u20146 weeks to 36 months (n = 161); and LSD (late symptomatic diagnosis) (n = 3080). P aeruginosa acquisition was determined from yearly sputum and\/or bronchoscopy cultures. Children whose CF diagnoses followed meconium ileus or whose cultures were obtained only from nasal samples were excluded from the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Kaplan Meier analyses for P aeruginosa acquisition were conducted for each diagnostic group. Regression models were used to generate adjusted relative hazards with EAD as the referent group. Relative hazards were 0.9 (95% confidence interval [CI]: 0.7\u20131.2) for ESD, 0.8 (95% CI: 0.6\u20131.2) for LAD, and 1.0 (95% CI: 0.7\u20131.2) for LSD. The risk of acquiringP aeruginosa was therefore not significantly different between children diagnosed early, late, asymptomatically, or symptomatically.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>These data suggest that, despite improvements in other health outcomes from newborn screening for CF, early asymptomatic diagnosis of CF does not affect P aeruginosa acquisition.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.107.2.274","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"274-279","source":"Crossref","is-referenced-by-count":44,"title":["Early Diagnosis of Cystic Fibrosis in the Newborn Period and Risk of <i>Pseudomonas aeruginosa<\/i> Acquisition in the First 10 Years of Life:  A Registry-Based Longitudinal Study"],"prefix":"10.1542","volume":"107","author":[{"given":"Sophia S.","family":"Wang","sequence":"first","affiliation":[{"name":"From the Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, and"},{"name":"Office of Genetics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey C.","family":"FitzSimmons","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"O'Leary","sequence":"additional","affiliation":[{"name":"Office of Genetics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rock","sequence":"additional","affiliation":[{"name":"University of Wisconsin Hospital and Clinics, Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta L.","family":"Gwinn","sequence":"additional","affiliation":[{"name":"Office of Genetics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muin J.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Office of Genetics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,2,1]]},"reference":[{"key":"2021121009503820700_B1"},{"key":"2021121009503820700_B2","first-page":"439","article-title":"Antibiotic use in cystic fibrosis.","volume":"2","author":"Eisenberg","year":"1996","journal-title":"Current Opinion In Pulmonary Medicine"},{"key":"2021121009503820700_B3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJM199607183350307","article-title":"Management of pulmonary disease in patients with cystic fibrosis.","volume":"335","author":"Ramsey","year":"1996","journal-title":"N Engl J Med."},{"key":"2021121009503820700_B4","first-page":"166","article-title":"Pulmonary infections in children with cystic fibrosis.","volume":"2","author":"Stutman","year":"1987","journal-title":"Semin Respir Infect."},{"key":"2021121009503820700_B5","first-page":"1","article-title":"Lung infection with alginate-producing, mucoidPseudomonas aeruginosa in cystic fibrosis.","volume":"100","author":"Pedersen","year":"1992","journal-title":"APMIS Supplementum."},{"key":"2021121009503820700_B6","first-page":"140","article-title":"Cystic fibrosis and the pseudomonads.","volume":"53","author":"Wright","year":"1996","journal-title":"Br J Biomed Sci."},{"key":"2021121009503820700_B7","first-page":"1291","article-title":"Treatment of cystic fibrosis in adults.","volume":"54","author":"Hamer","year":"1996","journal-title":"Am Fam Physician."},{"key":"2021121009503820700_B8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/infdis\/151.4.575","article-title":"Pulmonary disease associated with Pseudomonas aeruginosain cystic fibrosis: current status of the host-bacterium interaction.","volume":"151","author":"Pier","year":"1985","journal-title":"J Infect Dis."},{"key":"2021121009503820700_B9","first-page":"249","article-title":"Infections withPseudomonas aeruginosa in patients with cystic fibrosis.","volume":"98","author":"Tummler","year":"1997","journal-title":"Behring Insttitute Mitteilungen"},{"key":"2021121009503820700_B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00006454-199701000-00030","article-title":"Pathogenesis of bacterial bronchitis in cystic fibrosis.","volume":"16","author":"Smith","year":"1997","journal-title":"Pediatr Infect Dis J."},{"key":"2021121009503820700_B11","first-page":"168","article-title":"Emergence and persistence ofPseudomonas aeruginosa in the cystic fibrosis airway.","volume":"7","author":"Fick","year":"1992","journal-title":"Semin Respir Infect."},{"key":"2021121009503820700_B12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/thx.45.11.881","article-title":"Cystic fibrosis. Pseudomonas aeruginosainfection in cystic fibrosis and its management.","volume":"45","author":"Hoiby","year":"1990","journal-title":"Thorax."},{"key":"2021121009503820700_B13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/adc.57.8.582","article-title":"Pseudomonas infection, allergy, and cystic fibrosis.","volume":"57","author":"Pitcher-Wilmott","year":"1982","journal-title":"Arch Dis Child."},{"key":"2021121009503820700_B14"},{"key":"2021121009503820700_B15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thx.53.3.213","article-title":"Pseudomonas aeruginosa and other related species.","volume":"53","author":"Wilson","year":"1998","journal-title":"Thorax."},{"key":"2021121009503820700_B16"},{"key":"2021121009503820700_B17","first-page":"1","article-title":"Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development-proceedings of a 1997 workshop.","volume":"46","author":"Centers for Disease Control, and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121009503820700_B18"},{"key":"2021121009503820700_B19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM199710023371403","article-title":"Nutritional benefits of neonatal screening for cystic fibrosis.","volume":"337","author":"Farrell","year":"1997","journal-title":"N Engl J Med."},{"key":"2021121009503820700_B20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005176-199602000-00005","article-title":"Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.","volume":"22","author":"Freiman","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2021121009503820700_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis.","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"Pediatrics"},{"key":"2021121009503820700_B22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K","article-title":"Comprehensive analysis of risk factors for acquisition of pseudomonas aeruginosa in young children with cystic fibrosis.","volume":"26","author":"Kosorok","year":"1998","journal-title":"Pediatr Pulmonol."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/274\/891903\/274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/274\/891903\/274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:55:24Z","timestamp":1639173324000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/2\/274\/66330\/Early-Diagnosis-of-Cystic-Fibrosis-in-the-Newborn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,2,1]]},"published-print":{"date-parts":[[2001,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.2.274","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,1]]}}}